What we know about paracentesis induced circulatory dysfunction?
作者信息
Kim Jeong Han
机构信息
Department of Internal Medicine, Konkuk University School of Medicine, Seoul, Korea.
出版信息
Clin Mol Hepatol. 2015 Dec;21(4):349-51. doi: 10.3350/cmh.2015.21.4.349. Epub 2015 Dec 24.
Abstract
摘要
相似文献
1
What we know about paracentesis induced circulatory dysfunction?我们对腹腔穿刺术诱发的循环功能障碍了解多少？
Clin Mol Hepatol. 2015 Dec;21(4):349-51. doi: 10.3350/cmh.2015.21.4.349. Epub 2015 Dec 24.
2
Albumin May Prevent the Morbidity of Paracentesis-Induced Circulatory Dysfunction in Cirrhosis and Refractory Ascites: A Pilot Study.白蛋白可能预防肝硬化和顽固性腹水患者腹腔穿刺术诱发的循环功能障碍的发病：一项初步研究。
Dig Dis Sci. 2016 Oct;61(10):3084-3092. doi: 10.1007/s10620-016-4140-3. Epub 2016 Apr 5.
3
Prevention of paracentesis-induced circulatory dysfunction in cirrhosis: standard vs half albumin doses. A prospective, randomized, unblinded pilot study.预防肝硬化腹水穿刺引起的循环功能障碍：标准剂量与半剂量白蛋白。一项前瞻性、随机、非盲的初步研究。
Dig Liver Dis. 2011 Nov;43(11):881-6. doi: 10.1016/j.dld.2011.06.001. Epub 2011 Jul 8.
4
Beta-blockers cause paracentesis-induced circulatory dysfunction in patients with cirrhosis and refractory ascites: a cross-over study.β受体阻滞剂可引起肝硬化伴难治性腹水患者经皮穿刺放液后循环功能障碍：一项交叉研究。
J Hepatol. 2011 Oct;55(4):794-9. doi: 10.1016/j.jhep.2011.01.034. Epub 2011 Feb 24.
5
The impact of paracentesis flow rate in patients with liver cirrhosis on the development of paracentesis induced circulatory dysfunction.肝硬化患者腹腔穿刺引流流速对腹腔穿刺诱发循环功能障碍发生的影响
Clin Mol Hepatol. 2015 Dec;21(4):365-71. doi: 10.3350/cmh.2015.21.4.365. Epub 2015 Dec 24.
6
Terlipressin versus albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized study.特利加压素与白蛋白治疗肝硬化腹腔穿刺术诱发循环功能障碍的随机对照研究
J Gastroenterol Hepatol. 2006 Jan;21(1 Pt 2):303-7. doi: 10.1111/j.1440-1746.2006.04182.x.
7
Prevention of paracentesis-induced circulatory dysfunction: midodrine vs albumin. A randomized pilot study.预防腹腔穿刺术引起的循环功能障碍：米多君与白蛋白对比。一项随机试点研究。
Liver Int. 2008 Aug;28(7):1019-25. doi: 10.1111/j.1478-3231.2008.01734.x. Epub 2008 Apr 11.
8
Prevention of the Paracentesis-Induced Circulatory Dysfunction (PICD) in Cirrhosis: Is the SPA Treatment Worthwhile?肝硬化患者腹腔穿刺术诱发循环功能障碍（PICD）的预防：SPA治疗是否值得？
Dig Dis Sci. 2016 Oct;61(10):2773-2775. doi: 10.1007/s10620-016-4248-5. Epub 2016 Aug 23.
9
Noradrenaline and albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized pilot study.去甲肾上腺素和白蛋白在肝硬化穿刺放腹水诱发循环功能障碍中的作用：一项随机试点研究
J Intern Med. 2006 Jul;260(1):62-8. doi: 10.1111/j.1365-2796.2006.01654.x.
10
Comparison of midodrine and albumin in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients: a randomized pilot study.米多君与白蛋白预防肝硬化患者腹水穿刺诱导性循环功能障碍的比较：一项随机初步研究。
J Clin Gastroenterol. 2014 Feb;48(2):184-8. doi: 10.1097/MCG.0b013e31829ae376.
引用本文的文献
1
Serum sodium level is predictive for kidney injury or hyponatremia after modest-volume paracentesis (<5 L) in Asian patients with cirrhosis: A single-centered retrospective observational study.血清钠水平可预测亚洲肝硬化患者少量腹腔穿刺放液术（<5升）后发生肾损伤或低钠血症：一项单中心回顾性观察研究。
Medicine (Baltimore). 2025 Feb 7;104(6):e41420. doi: 10.1097/MD.0000000000041420.
2
Step by Step: Managing the Complications of Cirrhosis.循序渐进：肝硬化并发症的管理
Hepat Med. 2021 May 25;13:45-57. doi: 10.2147/HMER.S278032. eCollection 2021.
3
Current approaches to the management of patients with cirrhotic ascites.当前肝硬化腹水患者管理方法。
World J Gastroenterol. 2019 Jul 28;25(28):3738-3752. doi: 10.3748/wjg.v25.i28.3738.
本文引用的文献
1
The impact of paracentesis flow rate in patients with liver cirrhosis on the development of paracentesis induced circulatory dysfunction.肝硬化患者腹腔穿刺引流流速对腹腔穿刺诱发循环功能障碍发生的影响
Clin Mol Hepatol. 2015 Dec;21(4):365-71. doi: 10.3350/cmh.2015.21.4.365. Epub 2015 Dec 24.
2
Paracentesis-induced circulatory dysfunction: a primer for the interventional radiologist.腹腔穿刺术引起的循环功能障碍：介入放射科医生入门指南。
Semin Intervent Radiol. 2014 Sep;31(3):276-8. doi: 10.1055/s-0034-1382799.
3
Albumin reduces paracentesis-induced circulatory dysfunction and reduces death and renal impairment among patients with cirrhosis and infection: a systematic review and meta-analysis.白蛋白可减少肝硬化合并感染患者行腹腔穿刺术引起的循环功能障碍，降低死亡率和肾功能损害：系统评价和荟萃分析。
Biomed Res Int. 2013;2013:295153. doi: 10.1155/2013/295153. Epub 2013 Oct 8.
4
Effective albumin concentration and cirrhosis mortality: from concept to reality.有效白蛋白浓度与肝硬化死亡率：从概念到现实
J Hepatol. 2013 Nov;59(5):918-20. doi: 10.1016/j.jhep.2013.08.001. Epub 2013 Aug 13.
5
Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012.2012年美国肝病研究协会肝硬化所致成人腹水患者管理实践指南修订版介绍。
Hepatology. 2013 Apr;57(4):1651-3. doi: 10.1002/hep.26359.
6
Albumin: pathophysiologic basis of its role in the treatment of cirrhosis and its complications.白蛋白：在肝硬化及其并发症治疗中其作用的病理生理学基础。
Hepatology. 2013 Nov;58(5):1836-46. doi: 10.1002/hep.26338. Epub 2013 May 14.
7
Revision and update on clinical practice guideline for liver cirrhosis.肝硬化临床实践指南的修订与更新
Korean J Hepatol. 2012 Mar;18(1):1-21. doi: 10.3350/kjhep.2012.18.1.1. Epub 2012 Mar 22.
8
Albumin infusion in patients undergoing large-volume paracentesis: a meta-analysis of randomized trials.大量腹腔穿刺术患者输注白蛋白：随机试验的荟萃分析。
Hepatology. 2012 Apr;55(4):1172-81. doi: 10.1002/hep.24786.
9
EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis.欧洲肝脏研究学会肝硬化腹水、自发性细菌性腹膜炎和肝肾综合征管理临床实践指南
J Hepatol. 2010 Sep;53(3):397-417. doi: 10.1016/j.jhep.2010.05.004. Epub 2010 Jun 1.
10
Guidelines on the management of ascites in cirrhosis.肝硬化腹水管理指南
Gut. 2006 Oct;55 Suppl 6(Suppl 6):vi1-12. doi: 10.1136/gut.2006.099580.
Zotero 插件